{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:27:13Z","timestamp":1791214033978,"version":"4.1.0"},"reference-count":187,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.purol.2023.08.004","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T13:17:42Z","timestamp":1698758262000},"page":"911-953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["2022 Recommendations of the AFU Lithiasis Committee: Medical management\u00a0\u2013\u00a0from diagnosis to treatment"],"prefix":"10.1016","volume":"33","author":[{"given":"S.","family":"Lemoine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Dahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2756-2287","authenticated-orcid":false,"given":"J.P.","family":"Haymann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3180-8777","authenticated-orcid":false,"given":"P.","family":"Meria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1658-9177","authenticated-orcid":false,"given":"C.","family":"Almeras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.purol.2023.08.004_bib0940","series-title":"EAU guidelines on urolithiasis","year":"2022"},{"key":"10.1016\/j.purol.2023.08.004_bib0945","series-title":"Lithiase urinaire","author":"Daudon","year":"2012"},{"key":"10.1016\/j.purol.2023.08.004_bib0950","first-page":"955","article-title":"Bilan m\u00e9tabolique d\u2019une lithiase urinaire en pratique courante Travail commun des n\u00e9phrologues et urologues du Comit\u00e9 de la Lithiase de l\u2019Association Fran\u00e7aise d\u2019Urologie Comit\u00e9 de la Lithiase de l\u2019AFU","volume":"6","year":"1996","journal-title":"Prog Urol FMC"},{"key":"10.1016\/j.purol.2023.08.004_bib0955","first-page":"1077","article-title":"Idiopathic hypercalciuria: a preliminary report","volume":"46","author":"Albright","year":"1953","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.purol.2023.08.004_bib0960","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.semnephrol.2008.01.005","article-title":"New insights into the pathogenesis of idiopathic hypercalciuria","volume":"28","author":"Worcester","year":"2008","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.purol.2023.08.004_bib0965","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/bjs.18004619504","article-title":"The urinary excretion of calcium and inorganic phosphate in 344 patients with calcium stone of renal origin","volume":"46","author":"Hodgkinson","year":"1958","journal-title":"Br J Surg"},{"key":"10.1016\/j.purol.2023.08.004_bib0970","doi-asserted-by":"crossref","first-page":"73s","DOI":"10.1177\/014860718701100510","article-title":"Creatinine excretion as a measure of protein nutrition in adults of varying age","volume":"11","author":"Walser","year":"1987","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.purol.2023.08.004_bib0975","first-page":"321","article-title":"Investigation of single and recurrent stone formers","volume":"20","author":"Tiselius","year":"1994","journal-title":"Miner Electrolyte Metab"},{"key":"10.1016\/j.purol.2023.08.004_bib0980","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0090-4295(83)90113-9","article-title":"Low urinary citrate excretion in nephrolithiasis","volume":"21","author":"Nicar","year":"1983","journal-title":"Urology"},{"key":"10.1016\/j.purol.2023.08.004_bib0985","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.purol.2013.09.029","article-title":"[Update for the management of kidney stones in 2013. Lithiasis Committee of the French Association of Urology]","volume":"24","author":"Carpentier","year":"2014","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib0990","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.purol.2013.08.315","article-title":"[Management of adult's renal and ureteral stones. Update of the Lithiasis Committee of the French Association of Urology (CLAFU). General considerations]","volume":"23","author":"Chabannes","year":"2013","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib0995","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.purol.2013.06.014","article-title":"[First-line screening guidelines for renal stone disease patients: a CLAFU update]","volume":"24","author":"Haymann","year":"2014","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1000","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.juro.2014.05.006","article-title":"Medical management of kidney stones: AUA guideline","volume":"192","author":"Pearle","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1005","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/JU.0000000000001478","article-title":"Qualitative review of clinical guidelines for medical and surgical management of urolithiasis: consensus and controversy 2020","volume":"205","author":"Jiang","year":"2021","journal-title":"J Urol"},{"issue":"Suppl. 1","key":"10.1016\/j.purol.2023.08.004_bib1010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000046296","article-title":"Urine volume: stone risk factor and preventive measure","volume":"81","author":"Borghi","year":"1999","journal-title":"Nephron"},{"key":"10.1016\/j.purol.2023.08.004_bib1015","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1046\/j.1523-1755.1999.0550031041.x","article-title":"Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers","volume":"55","author":"Borghi","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.purol.2023.08.004_bib1020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.7326\/0003-4819-93-1-36","article-title":"Evidence justifying a high fluid intake in treatment of nephrolithiasis","volume":"93","author":"Pak","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.purol.2023.08.004_bib1025","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1056\/NEJM199303253281203","article-title":"A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones","volume":"328","author":"Curhan","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.purol.2023.08.004_bib1030","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2215\/CJN.11661112","article-title":"Soda and other beverages and the risk of kidney stones","volume":"8","author":"Ferraro","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.purol.2023.08.004_bib1035","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.euf.2019.05.002","article-title":"Fluid intake and dietary factors and the risk of incident kidney stones in UK Biobank: a population-based prospective cohort study","volume":"6","author":"Littlejohns","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.purol.2023.08.004_bib1040","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1055\/s-2007-979929","article-title":"Increase in urinary calcium and oxalate after fructose infusion","volume":"27","author":"Nguyen","year":"1995","journal-title":"Hormone Metab Res"},{"key":"10.1016\/j.purol.2023.08.004_bib1045","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1055\/s-0030-1265145","article-title":"Metabolism of fructose to oxalate and glycolate","volume":"42","author":"Knight","year":"2010","journal-title":"Hormone Metab Res"},{"key":"10.1016\/j.purol.2023.08.004_bib1050","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0026-0495(72)90120-5","article-title":"Studies on the mechanism of fructose-induced hyperuricemia in man","volume":"21","author":"Fox","year":"1972","journal-title":"Metabolism"},{"key":"10.1016\/j.purol.2023.08.004_bib1055","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/sj.ki.5002588","article-title":"Fructose consumption and the risk of kidney stones","volume":"73","author":"Taylor","year":"2008","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.purol.2023.08.004_bib1060","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.3390\/nu13114117","article-title":"Role of citrus fruit juices in prevention of kidney stone disease (KSD): a narrative review","volume":"13","author":"Barghouthy","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.purol.2023.08.004_bib1065","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00240-008-0152-6","article-title":"Can lemon juice be an alternative to potassium citrate in the treatment of urinary calcium stones in patients with hypocitraturia? A prospective randomized study","volume":"36","author":"Aras","year":"2008","journal-title":"Urol Res"},{"key":"10.1016\/j.purol.2023.08.004_bib1070","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.urology.2007.06.1115","article-title":"Lemonade therapy increases urinary citrate and urine volumes in patients with recurrent calcium oxalate stone formation","volume":"70","author":"Penniston","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.purol.2023.08.004_bib1075","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.urology.2007.02.008","article-title":"Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation","volume":"69","author":"Koff","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.purol.2023.08.004_bib1080","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.2215\/CJN.00800306","article-title":"Comparative value of orange juice versus lemonade in reducing stone-forming risk","volume":"1","author":"Odvina","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.purol.2023.08.004_bib1085","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0022-5347(01)65659-3","article-title":"Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis","volume":"156","author":"Seltzer","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1090","doi-asserted-by":"crossref","first-page":"101227","DOI":"10.1016\/j.eclinm.2021.101227","article-title":"Fresh lemon juice supplementation for the prevention of recurrent stones in calcium oxalate nephrolithiasis: a pragmatic, prospective, randomised, open, blinded endpoint (PROBE) trial","volume":"43","author":"Ruggenenti","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.purol.2023.08.004_bib1095","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1046\/j.1464-410x.1999.00216.x","article-title":"A prospective study of nonmedical prophylaxis after a first kidney stone","volume":"84","author":"Kocvara","year":"1999","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2023.08.004_bib1100","first-page":"265","article-title":"Salt intake, urinary sodium, and hypercalciuria","volume":"23","author":"Cirillo","year":"1997","journal-title":"Miner Electrolyte Metab"},{"key":"10.1016\/j.purol.2023.08.004_bib1105","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0022-5347(17)35468-X","article-title":"The potential role of salt abuse on the risk for kidney stone formation","volume":"150","author":"Sakhaee","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1475-2891-10-3","article-title":"The role of salt abuse on risk for hypercalciuria","volume":"10","author":"Damasio","year":"2011","journal-title":"Nutr J"},{"key":"10.1016\/j.purol.2023.08.004_bib1115","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3945\/ajcn.2009.28614","article-title":"Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial","volume":"91","author":"Nouvenne","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.purol.2023.08.004_bib1120","doi-asserted-by":"crossref","first-page":"497","DOI":"10.7326\/0003-4819-126-7-199704010-00001","article-title":"Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women","volume":"126","author":"Curhan","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.purol.2023.08.004_bib1125","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000067985","article-title":"Effects of a \u2018common sense diet\u2019 on urinary composition and supersaturation in patients with idiopathic calcium urolithiasis","volume":"36","author":"Hess","year":"1999","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1130","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJMoa010369","article-title":"Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria","volume":"346","author":"Borghi","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.purol.2023.08.004_bib1135","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0090-4295(02)01908-8","article-title":"Biochemical distinction between hyperuricosuric calcium urolithiasis and gouty diathesis","volume":"60","author":"Pak","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.purol.2023.08.004_bib1140","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1046\/j.1523-1755.2001.060002757.x","article-title":"Biochemical profile of idiopathic uric acid nephrolithiasis","volume":"60","author":"Pak","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.purol.2023.08.004_bib1145","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ki.1996.27","article-title":"Urinary oxalate excretion increases with body size and decreases with increasing dietary calcium intake among healthy adults","volume":"49","author":"Lemann","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.purol.2023.08.004_bib1150","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/ndt\/13.9.2241","article-title":"High-calcium intake abolishes hyperoxaluria and reduces urinary crystallization during a 20-fold normal oxalate load in humans","volume":"13","author":"Hess","year":"1998","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl. 2","key":"10.1016\/j.purol.2023.08.004_bib1155","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1038\/sj.ejcn.1601901","article-title":"Fluid intake and epidemiology of urolithiasis","volume":"57","author":"Siener","year":"2003","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.purol.2023.08.004_bib1160","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0022-5347(17)51073-3","article-title":"Effect of calcium restriction on renal excretion of oxalate and the probability of stones in the various pathophysiological groups with calcium stones","volume":"130","author":"Bataille","year":"1983","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1165","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1097\/01.ASN.0000127864.26968.7F","article-title":"Dependence of oxalate absorption on the daily calcium intake","volume":"15","author":"von Unruh","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.purol.2023.08.004_bib1170","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.2215\/CJN.01410308","article-title":"Determinants of 24-hour urinary oxalate excretion","volume":"3","author":"Taylor","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.purol.2023.08.004_bib1175","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00240-015-0846-5","article-title":"The management of patients with enteric hyperoxaluria","volume":"44","author":"Asplin","year":"2016","journal-title":"Urolithiasis"},{"key":"10.1016\/j.purol.2023.08.004_bib1180","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.eururo.2009.03.031","article-title":"Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials","volume":"56","author":"Fink","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1185","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/ki.1991.151","article-title":"Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers","volume":"39","author":"Bataille","year":"1991","journal-title":"Kidney Int"},{"key":"10.1016\/j.purol.2023.08.004_bib1190","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2215\/CJN.10191110","article-title":"Determinants of osteopenia in male renal-stone-disease patients with idiopathic hypercalciuria","volume":"6","author":"Letavernier","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.purol.2023.08.004_bib1195","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1359\/jbmr.2001.16.10.1893","article-title":"Bone mineral density and fracture among prevalent kidney stone cases in the Third National Health and Nutrition Examination Survey","volume":"16","author":"Lauderdale","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.purol.2023.08.004_bib1200","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/j.ajkd.2015.09.005","article-title":"Total, dietary, and supplemental vitamin C intake and risk of incident kidney stones","volume":"67","author":"Ferraro","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.purol.2023.08.004_bib1205","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1038\/sj.ki.5001906","article-title":"Hydroxyproline ingestion and urinary oxalate and glycolate excretion","volume":"70","author":"Knight","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.purol.2023.08.004_bib1210","doi-asserted-by":"crossref","DOI":"10.3390\/nu11051182","article-title":"Which diet for calcium stone patients: a real-world approach to preventive care","volume":"11","author":"D\u2019Alessandro","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.purol.2023.08.004_bib1215","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1464-410X.1991.tb15125.x","article-title":"Results of long-term rice bran treatment on stone recurrence in hypercalciuric patients","volume":"67","author":"Ebisuno","year":"1991","journal-title":"Br J Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1220","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/oxfordjournals.aje.a008851","article-title":"Randomized controlled trial of a low animal protein, high fiber diet in the prevention of recurrent calcium oxalate kidney stones","volume":"144","author":"Hiatt","year":"1996","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.purol.2023.08.004_bib1225","doi-asserted-by":"crossref","first-page":"c185","DOI":"10.1159\/000167271","article-title":"A randomized trial of low-animal-protein or high-fiber diets for secondary prevention of calcium nephrolithiasis","volume":"110","author":"Dussol","year":"2008","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.purol.2023.08.004_bib1230","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10654-014-9904-5","article-title":"Diet and risk of kidney stones in the Oxford cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC)","volume":"29","author":"Turney","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.purol.2023.08.004_bib1235","first-page":"1559","article-title":"[Evaluation of the lithogenic risk in renal lithiasis. Value of urine density measurement]","volume":"24","author":"Hennequin","year":"1995","journal-title":"Presse Med"},{"key":"10.1016\/j.purol.2023.08.004_bib1240","doi-asserted-by":"crossref","first-page":"535","DOI":"10.7326\/0003-4819-158-7-201304020-00005","article-title":"Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline","volume":"158","author":"Fink","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.purol.2023.08.004_bib1245","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1111\/j.1523-1755.2005.00292.x","article-title":"Serial crystalluria determination and the risk of recurrence in calcium stone formers","volume":"67","author":"Daudon","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.purol.2023.08.004_bib1250","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/art.20821","article-title":"Beer, liquor, and wine consumption and serum uric acid level: the Third National Health and Nutrition Examination Survey","volume":"51","author":"Choi","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.purol.2023.08.004_bib1255","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/jps.2600650345","article-title":"Pharmacokinetic analysis of renal handling of sulfamethizole","volume":"65","author":"Hori","year":"1976","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.purol.2023.08.004_bib1260","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1172\/JCI24134","article-title":"Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia","volume":"115","author":"Nijenhuis","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.purol.2023.08.004_bib1265","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(81)90302-0","article-title":"Do thiazides prevent recurrent idiopathic renal calcium stones?","volume":"2","author":"Brocks","year":"1981","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.purol.2023.08.004_bib1270","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0022-5347(17)53269-3","article-title":"Double-blind study with thiazide in recurrent calcium lithiasis","volume":"128","author":"Scholz","year":"1982","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1275","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF02082712","article-title":"Thiazides in the prophylactic treatment of recurrent idiopathic kidney stones","volume":"18","author":"Mortensen","year":"1986","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.purol.2023.08.004_bib1280","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJMoa2209275","article-title":"Hydrochlorothiazide and prevention of kidney-stone recurrence","volume":"388","author":"Dhayat","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.purol.2023.08.004_bib1285","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12967-020-02270-7","article-title":"Use of thiazide diuretics for the prevention of recurrent kidney calculi: a systematic review and meta-analysis","volume":"18","author":"Li","year":"2020","journal-title":"J Transl Med"},{"key":"10.1016\/j.purol.2023.08.004_bib1290","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s11255-010-9824-6","article-title":"Thiazides diuretics in the treatment of nephrolithiasis: are we using them in an evidence-based fashion?","volume":"43","author":"Vigen","year":"2011","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.purol.2023.08.004_bib1295","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/jamainternmed.2016.6821","article-title":"Association of 3 different antihypertensive medications with hip and pelvic fracture risk in older adults: secondary analysis of a randomized clinical trial","volume":"177","author":"Puttnam","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.purol.2023.08.004_bib1300","doi-asserted-by":"crossref","first-page":"101589","DOI":"10.1016\/j.bonr.2022.101589","article-title":"Thiazide use and skeletal microstructure: results from a multi-ethnic study","volume":"16","author":"Huynh","year":"2022","journal-title":"Bone Rep"},{"key":"10.1016\/j.purol.2023.08.004_bib1305","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0022-5347(17)50438-3","article-title":"Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis","volume":"131","author":"Nicar","year":"1984","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1310","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1046\/j.1523-1755.2003.00719.x","article-title":"Long-term combined treatment with thiazide and potassium citrate in nephrolithiasis does not lead to hypokalemia or hypochloremic metabolic alkalosis","volume":"63","author":"Odvina","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.purol.2023.08.004_bib1315","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1517\/14656566.2013.775250","article-title":"Kidney stones: an update on current pharmacological management and future directions","volume":"14","author":"Xu","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.purol.2023.08.004_bib1320","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.0954-6820.1984.tb05023.x","article-title":"Thiazide prophylaxis of urolithiasis. A double-blind study in general practice","volume":"215","author":"Laerum","year":"1984","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.purol.2023.08.004_bib1325","first-page":"994","article-title":"Comparison of medical treatments for the prevention of recurrent calcium nephrolithiasis","volume":"25","author":"Wilson","year":"1984","journal-title":"Kidney Int"},{"key":"10.1016\/j.purol.2023.08.004_bib1330","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1042\/cs0690511","article-title":"Effect of chlorothiazide on serial measurements of exchangeable sodium and blood pressure in spontaneously hypertensive rats","volume":"69","author":"Manhem","year":"1985","journal-title":"Clin Sci"},{"key":"10.1016\/j.purol.2023.08.004_bib1335","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0022-5347(17)42599-7","article-title":"Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not","volume":"139","author":"Ettinger","year":"1988","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1340","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1464-410X.1992.tb15624.x","article-title":"Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria","volume":"69","author":"Ohkawa","year":"1992","journal-title":"Br J Urol"},{"issue":"Suppl. 6","key":"10.1016\/j.purol.2023.08.004_bib1345","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1097\/00005344-199312050-00014","article-title":"Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences","volume":"22","author":"Borghi","year":"1993","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.purol.2023.08.004_bib1350","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0210-4806(06)73444-1","article-title":"[The role of thiazides in the prophylaxis of recurrent calcium lithiasis]","volume":"30","author":"Fern\u00e1ndez-Rodr\u00edguez","year":"2006","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.purol.2023.08.004_bib1355","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s11255-021-02879-7","article-title":"Potassium citrate vs. hydrochlorothiazide to reduce urinary calcium excretion in calcium oxalate stone patients with hypercalciuria: a prospective randomized study","volume":"53","author":"Solak","year":"2021","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.purol.2023.08.004_bib1360","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0272-6386(12)80635-4","article-title":"Citrate and renal calculi: new insights and future directions","volume":"17","author":"Pak","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.purol.2023.08.004_bib1365","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0272-6386(12)81057-2","article-title":"Calcium oxalate stone agglomeration reflects stone-forming activity: citrate inhibition depends on macromolecules larger than 30 kilodalton","volume":"24","author":"Erwin","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.purol.2023.08.004_bib1370","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/ndt\/15.3.366","article-title":"Citrate determines calcium oxalate crystallization kinetics and crystal morphology-studies in the presence of Tamm-Horsfall protein of a healthy subject and a severely recurrent calcium stone former","volume":"15","author":"Hess","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.purol.2023.08.004_bib1375","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.purol.2008.02.004","article-title":"[Characteristics of encrustation of ureteric stents in patients with urinary stones]","volume":"18","author":"Bouzidi","year":"2008","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1380","first-page":"650","article-title":"[Influence of urinary citrate levels on spontaneous calcium oxalate dihydrate crystalluria]","volume":"15","author":"Hassani","year":"2005","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1385","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00240-005-0464-8","article-title":"Preventive treatment of nephrolithiasis with alkali citrate\u00a0\u2013\u00a0a critical review","volume":"33","author":"Mattle","year":"2005","journal-title":"Urol Res"},{"key":"10.1016\/j.purol.2023.08.004_bib1390","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0022-5347(17)35888-3","article-title":"Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis","volume":"150","author":"Barcelo","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1395","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/089277902753716098","article-title":"Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial","volume":"16","author":"Soyg\u00fcr","year":"2002","journal-title":"J Endourol"},{"key":"10.1016\/j.purol.2023.08.004_bib1400","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1464-410X.1994.tb07597.x","article-title":"Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis\u2013a prospective randomized study","volume":"73","author":"Hofbauer","year":"1994","journal-title":"Br J Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1405","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/S0022-5347(01)68155-2","article-title":"Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis","volume":"158","author":"Ettinger","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1410","first-page":"Cd010057","article-title":"Citrate salts for preventing and treating calcium containing kidney stones in adults","author":"Phillips","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.purol.2023.08.004_bib1415","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0022-5347(17)34858-9","article-title":"Effect of alkaline citrate therapy on clearance of residual renal stone fragments after extracorporeal shock wave lithotripsy in sterile calcium and infection nephrolithiasis patients","volume":"151","author":"Cicerello","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1420","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4111\/kju.2014.55.6.411","article-title":"Effect of potassium magnesium citrate and vitamin B-6 prophylaxis for recurrent and multiple calcium oxalate and phosphate urolithiasis","volume":"55","author":"Reddy","year":"2014","journal-title":"Korean J Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1425","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/ki.1983.165","article-title":"Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts","volume":"24","author":"Sakhaee","year":"1983","journal-title":"Kidney Int"},{"key":"10.1016\/j.purol.2023.08.004_bib1430","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00467-020-04693-2","article-title":"Efficacy and safety of an innovative prolonged-release combination drug in patients with distal renal tubular acidosis: an open-label comparative trial versus standard of care treatments","volume":"36","author":"Bertholet-Thomas","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.purol.2023.08.004_bib1435","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13023-022-02294-w","article-title":"Lived experiences of patients with distal renal tubular acidosis treated with ADV7103 and of their caregivers: a qualitative study","volume":"17","author":"Acquadro","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.purol.2023.08.004_bib1440","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00467-020-04873-0","article-title":"Safety, efficacy, and acceptability of ADV7103 during 24 months of treatment: an open-label study in pediatric and adult patients with distal renal tubular acidosis","volume":"36","author":"Bertholet-Thomas","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.purol.2023.08.004_bib1445","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.urology.2013.03.002","article-title":"The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers","volume":"82","author":"Pinheiro","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.purol.2023.08.004_bib1450","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000083560","article-title":"Importance of magnesium in absorption and excretion of oxalate","volume":"74","author":"Zimmermann","year":"2005","journal-title":"Urol Int"},{"key":"10.1016\/j.purol.2023.08.004_bib1455","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1089\/end.2013.0173","article-title":"Effect of magnesium on calcium and oxalate ion binding","volume":"27","author":"Riley","year":"2013","journal-title":"J Endourol"},{"key":"10.1016\/j.purol.2023.08.004_bib1460","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0924-8579(02)00088-2","article-title":"Urinary infection stones","volume":"19","author":"Bichler","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.purol.2023.08.004_bib1465","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ucl.2007.05.006","article-title":"Pathophysiology and management of infectious staghorn calculi","volume":"34","author":"Healy","year":"2007","journal-title":"Urol Clin N Am"},{"key":"10.1016\/j.purol.2023.08.004_bib1470","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0094-0143(05)70360-8","article-title":"Treatment options in struvite stones","volume":"24","author":"Wang","year":"1997","journal-title":"Urol Clin N Am"},{"key":"10.1016\/j.purol.2023.08.004_bib1475","first-page":"5","article-title":"Infections and urolithiasis: current clinical evidence in prophylaxis and antibiotic therapy","volume":"80","author":"Zanetti","year":"2008","journal-title":"Arch Ital Urol Androl"},{"key":"10.1016\/j.purol.2023.08.004_bib1480","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1089\/end.2013.0257","article-title":"Contemporary management of struvite stones using combined endourologic and medical treatment: predictors of unfavorable clinical outcome","volume":"30","author":"Iqbal","year":"2016","journal-title":"J Endourol"},{"key":"10.1016\/j.purol.2023.08.004_bib1485","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1097\/01.ju.0000161171.67806.2a","article-title":"Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations","volume":"173","author":"Preminger","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1490","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/003655901753224387","article-title":"Chemolysis of struvite stones by acidification of artificial urine\u2013an in vitro study","volume":"35","author":"Jacobs","year":"2001","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.purol.2023.08.004_bib1495","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000281732","article-title":"Long-term acidification of urine in patients treated for infected renal stones","volume":"45","author":"Wall","year":"1990","journal-title":"Urol Int"},{"key":"10.1016\/j.purol.2023.08.004_bib1500","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.urology.2016.08.007","article-title":"Effect of L-methionine on the risk of phosphate stone formation","volume":"98","author":"Siener","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.purol.2023.08.004_bib1505","first-page":"112","article-title":"Struvite stones: long-term follow-up under metaphylaxis","volume":"30","author":"Jarrar","year":"1996","journal-title":"Ann Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1510","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00041552-200403000-00006","article-title":"Novel insights into the pathogenesis of uric acid nephrolithiasis","volume":"13","author":"Maalouf","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.purol.2023.08.004_bib1515","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1053\/j.ajkd.2017.01.053","article-title":"Development of Nephrolithiasis in asymptomatic hyperuricemia: a cohort study","volume":"70","author":"Kim","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.purol.2023.08.004_bib1520","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/archinte.1986.00360170059007","article-title":"Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate","volume":"146","author":"Pak","year":"1986","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.purol.2023.08.004_bib1525","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000475190","article-title":"Clinical and biochemical features of uric acid nephrolithiasis","volume":"27","author":"Ito","year":"1995","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1530","first-page":"188","article-title":"Dissolution of radiolucent renal stones by oral alkalinization with potassium citrate\/potassium bicarbonate","volume":"81","author":"Trinchieri","year":"2009","journal-title":"Arch Ital Urol Androl"},{"key":"10.1016\/j.purol.2023.08.004_bib1535","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00240-020-01204-8","article-title":"Oral chemolysis is an effective, non-invasive therapy for urinary stones suspected of uric acid content","volume":"48","author":"Tsaturyan","year":"2020","journal-title":"Urolithiasis"},{"key":"10.1016\/j.purol.2023.08.004_bib1540","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0094-0143(21)01278-7","article-title":"Hyperuricosuria and calcium nephrolithiasis","volume":"8","author":"Coe","year":"1981","journal-title":"Urol Clin N Am"},{"key":"10.1016\/j.purol.2023.08.004_bib1545","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.juro.2018.09.027","article-title":"Can we predict the outcome of oral dissolution therapy for radiolucent renal calculi? A prospective study","volume":"201","author":"Elsawy","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1550","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.juro.2012.09.102","article-title":"Gout, stone composition and urinary stone risk: a matched case comparative study","volume":"189","author":"Marchini","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1555","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1056\/NEJM198611273152204","article-title":"Randomized trial of allopurinol in the prevention of calcium oxalate calculi","volume":"315","author":"Ettinger","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.purol.2023.08.004_bib1560","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/ki.1978.60","article-title":"Hyperuricosuric calcium oxalate nephrolithiasis","volume":"13","author":"Coe","year":"1978","journal-title":"Kidney Int"},{"key":"10.1016\/j.purol.2023.08.004_bib1565","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/ki.1982.183","article-title":"Pathogenesis and clinical course of mixed calcium oxalate and uric acid nephrolithiasis","volume":"22","author":"Millman","year":"1982","journal-title":"Kidney Int"},{"key":"10.1016\/j.purol.2023.08.004_bib1570","first-page":"1151","article-title":"[Composition of renal stones currently observed in non-industrialized countries]","volume":"14","author":"Daudon","year":"2004","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1575","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s004670050728","article-title":"Urolithiasis in Tunisian children: a study of 120 cases based on stone composition","volume":"13","author":"Kamoun","year":"1999","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.purol.2023.08.004_bib1580","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1159\/000186649","article-title":"Blood and urinary aggregator and inhibitor composition in controls and renal-stone patients from northeastern Thailand","volume":"59","author":"Sriboonlue","year":"1991","journal-title":"Nephron"},{"key":"10.1016\/j.purol.2023.08.004_bib1585","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0272-6386(97)90058-5","article-title":"Ammonium acid urate crystal formation in adult North American stone-formers","volume":"30","author":"Pichette","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.purol.2023.08.004_bib1590","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.kjms.2011.11.004","article-title":"Clinical study of ammonium acid urate urolithiasis","volume":"28","author":"Chou","year":"2012","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.purol.2023.08.004_bib1595","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2174\/1381612033455125","article-title":"Infections and urinary stone disease","volume":"9","author":"Rahman","year":"2003","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.purol.2023.08.004_bib1600","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0022-5347(17)39923-8","article-title":"Laxative abuse as a cause for ammonium urate renal calculi","volume":"143","author":"Dick","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1605","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJMoa035700","article-title":"Purine-rich foods, dairy and protein intake, and the risk of gout in men","volume":"350","author":"Choi","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.purol.2023.08.004_bib1610","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s00467-021-05342-y","article-title":"an update on pathophysiology, genetics, and clinical management","volume":"37","author":"D\u2019Ambrosio","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.purol.2023.08.004_bib1615","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ucl.2007.04.006","article-title":"Management of cystinuria","volume":"34","author":"Rogers","year":"2007","journal-title":"Urol Clin N Am"},{"key":"10.1016\/j.purol.2023.08.004_bib1620","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00467-004-1663-1","article-title":"Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up","volume":"20","author":"Knoll","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.purol.2023.08.004_bib1625","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1159\/000188760","article-title":"The effect of sodium intake on cystinuria with and without tiopronin treatment","volume":"71","author":"Lindell","year":"1995","journal-title":"Nephron"},{"key":"10.1016\/j.purol.2023.08.004_bib1630","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0022-5347(17)40222-9","article-title":"Dietary restriction of sodium as a means of reducing urinary cystine","volume":"143","author":"Norman","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1635","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/bju.14721","article-title":"Adverse events associated with currently used medical treatments for cystinuria and treatment goals: results from a series of 442 patients in France","volume":"124","author":"Prot-Bertoye","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2023.08.004_bib1640","first-page":"473","article-title":"[Cystinuria: from diagnosis to follow-up]","volume":"65","author":"Bouzidi","year":"2007","journal-title":"Ann Biol Clin"},{"key":"10.1016\/j.purol.2023.08.004_bib1645","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s002400100201","article-title":"Cystine analyses of separate day and night urine as a basis for the management of patients with homozygous cystinuria","volume":"29","author":"Fjellstedt","year":"2001","journal-title":"Urol Res"},{"key":"10.1016\/j.purol.2023.08.004_bib1650","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.eururo.2015.07.041","article-title":"EAU guidelines on interventional treatment for urolithiasis","volume":"69","author":"T\u00fcrk","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1655","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00307941","article-title":"Clinical course and cystine stone formation during tiopronin treatment","volume":"23","author":"Lindell","year":"1995","journal-title":"Urol Res"},{"key":"10.1016\/j.purol.2023.08.004_bib1660","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00240-019-01128-y","article-title":"Effect of increasing doses of cystine-binding thiol drugs on cystine capacity in patients with cystinuria","volume":"47","author":"Malieckal","year":"2019","journal-title":"Urolithiasis"},{"key":"10.1016\/j.purol.2023.08.004_bib1665","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1089\/end.2005.19.429","article-title":"Effect of cystine-binding thiol drugs on urinary cystine capacity in patients with cystinuria","volume":"19","author":"Dolin","year":"2005","journal-title":"J Endourol"},{"key":"10.1016\/j.purol.2023.08.004_bib1670","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1089\/end.2015.0692","article-title":"Can the presence of crystalluria predict stone formation in patients with cystinuria?","volume":"30","author":"Wong","year":"2016","journal-title":"J Endourol"},{"key":"10.1016\/j.purol.2023.08.004_bib1675","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00240-003-0319-0","article-title":"Cystine crystal volume determination: a useful tool in the management of cystinuric patients","volume":"31","author":"Daudon","year":"2003","journal-title":"Urol Res"},{"key":"10.1016\/j.purol.2023.08.004_bib1680","first-page":"273","article-title":"The effect of dietary protein on cystine excretion in patients with cystinuria","volume":"22","author":"Rodman","year":"1984","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.purol.2023.08.004_bib1685","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1373\/clinchem.2010.161547","article-title":"Necessity of fractionated urine collection for monitoring patients with cystinuria","volume":"57","author":"van Hoeve","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.purol.2023.08.004_bib1690","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.kint.2020.06.035","article-title":"Cystinuria: clinical practice recommendation","volume":"99","author":"Servais","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.purol.2023.08.004_bib1695","article-title":"Genetic assessment in primary hyperoxaluria: why it matters","author":"Mandrile","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.purol.2023.08.004_bib1700","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa2021712","article-title":"Lumasiran, an RNAi therapeutic for primary hyperoxaluria type 1","volume":"384","author":"Garrelfs","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.purol.2023.08.004_bib1705","series-title":"Protocole National de Diagnostic et de Soins (PNDS)\u00a0: hyperoxalurie","year":"2022"},{"key":"10.1016\/j.purol.2023.08.004_bib1710","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41581-022-00661-1","article-title":"Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope","volume":"19","author":"Groothoff","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.purol.2023.08.004_bib1715","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.eururo.2014.10.029","article-title":"Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines","volume":"67","author":"Skolarikos","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1720","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00240-018-1041-2","article-title":"Upper metastable limit osmolality of urine as a predictor of kidney stone formation in children","volume":"47","author":"Porowski","year":"2019","journal-title":"Urolithiasis"},{"key":"10.1016\/j.purol.2023.08.004_bib1725","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00467-004-1779-3","article-title":"Role of urinary supersaturation in the evaluation of children with urolithiasis","volume":"20","author":"Lande","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.purol.2023.08.004_bib1730","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF00864405","article-title":"Management of primary hyperoxaluria: efficacy of oral citrate administration","volume":"7","author":"Leumann","year":"1993","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.purol.2023.08.004_bib1735","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/ki.2009.237","article-title":"Effect of conservative treatment on the renal outcome of children with primary hyperoxaluria type 1","volume":"76","author":"Fargue","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.purol.2023.08.004_bib1740","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s11255-018-1939-1","article-title":"Metabolic profile and impact of diet in patients with primary hyperoxaluria","volume":"50","author":"Siener","year":"2018","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.purol.2023.08.004_bib1745","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/ki.2008.63","article-title":"[13C2]oxalate absorption in children with idiopathic calcium oxalate urolithiasis or primary hyperoxaluria","volume":"73","author":"Sikora","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.purol.2023.08.004_bib1750","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10545-017-0105-8","article-title":"Correlation between the molecular effects of mutations at the dimer interface of alanine-glyoxylate aminotransferase leading to primary hyperoxaluria type I and the cellular response to vitamin B(6)","volume":"41","author":"Dindo","year":"2018","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.purol.2023.08.004_bib1755","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1053\/j.ajkd.2020.07.017","article-title":"Recovery from dialysis in patients with primary hyperoxaluria type 1 treated with pyridoxine: a report of 3 cases","volume":"77","author":"Lorenz","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.purol.2023.08.004_bib1760","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1056\/NEJM199412083312304","article-title":"Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria","volume":"331","author":"Milliner","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.purol.2023.08.004_bib1765","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000085411","article-title":"Implications of genotype and enzyme phenotype in pyridoxine response of patients with type I primary hyperoxaluria","volume":"25","author":"Monico","year":"2005","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.purol.2023.08.004_bib1770","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.ekir.2020.04.004","article-title":"Pyridoxine responsiveness in a type 1 primary hyperoxaluria patient with a rare (Atypical) AGXT gene mutation","volume":"5","author":"Singh","year":"2020","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.purol.2023.08.004_bib1775","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1111\/j.1523-1755.2005.00267.x","article-title":"Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele","volume":"67","author":"Monico","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.purol.2023.08.004_bib1780","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/ki.2009.32","article-title":"The primary hyperoxalurias","volume":"75","author":"Hoppe","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.purol.2023.08.004_bib1785","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2215\/CJN.06820613","article-title":"Vitamin B6 in primary hyperoxaluria I: first prospective trial after 40 years of practice","volume":"9","author":"Hoyer-Kuhn","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.purol.2023.08.004_bib1790","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2215\/CJN.14730920","article-title":"Phase 1\/2 study of lumasiran for treatment of primary hyperoxaluria type 1: a placebo-controlled randomized clinical trial","volume":"16","author":"Frishberg","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.purol.2023.08.004_bib1795","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/j.ajkd.2022.05.012","article-title":"Lumasiran for advanced primary hyperoxaluria type 1: phase 3 ILLUMINATE-C Trial","volume":"81","author":"Michael","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.purol.2023.08.004_bib1800","article-title":"Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 12-month analysis of the phase 3 ILLUMINATE-B trial","author":"Hayes","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.purol.2023.08.004_bib1805","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0016-5085(74)80003-X","article-title":"Hyperoxaluria in patients with ileal resection: an abnormality in dietary oxalate absorption","volume":"66","author":"Earnest","year":"1974","journal-title":"Gastroenterology"},{"key":"10.1016\/j.purol.2023.08.004_bib1810","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1056\/NEJM197702102960602","article-title":"Importance of the colon in enteric hyperoxaluria","volume":"296","author":"Dobbins","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.purol.2023.08.004_bib1815","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2215\/CJN.08000520","article-title":"Pathophysiology and treatment of enteric hyperoxaluria","volume":"16","author":"Witting","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.purol.2023.08.004_bib1820","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/MNH.0000000000000690","article-title":"Gut-kidney axis in oxalate homeostasis","volume":"30","author":"Alshaikh","year":"2021","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.purol.2023.08.004_bib1825","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1046\/j.1442-2042.2001.00264.x","article-title":"Inhibition of calcium oxalate precipitation by bile salts","volume":"8","author":"Saso","year":"2001","journal-title":"Int J Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1830","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/BF01076170","article-title":"Hyperoxaluria and intestinal disease. The role of steatorrhea and dietary calcium in regulating intestinal oxalate absorption","volume":"22","author":"Stauffer","year":"1977","journal-title":"Am J Dig Dis"},{"key":"10.1016\/j.purol.2023.08.004_bib1835","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0022-5347(17)60082-X","article-title":"Excretion of calcium and citric acid in patients with small bowel disease","volume":"111","author":"Elliot","year":"1974","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1840","article-title":"Plasma citrate homeostasis: how it is regulated; and its physiological and clinical implications. An important, but neglected, relationship in medicine","volume":"1","author":"Costello","year":"2016","journal-title":"HSOA J Hum Endocrinol"},{"key":"10.1016\/j.purol.2023.08.004_bib1845","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/ki.2011.287","article-title":"Hyperoxaluria:a gut-kidney axis?","volume":"80","author":"Robijn","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.purol.2023.08.004_bib1850","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1056\/NEJM197307262890402","article-title":"Mechanism for hyperoxaluria in patients with ileal dysfunction","volume":"289","author":"Chadwick","year":"1973","journal-title":"N Engl J Med"},{"key":"10.1016\/j.purol.2023.08.004_bib1855","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/gut.15.5.360","article-title":"Fat-reduced diet in the treatment of hyperoxaluria in patients with ileopathy","volume":"15","author":"Andersson","year":"1974","journal-title":"Gut"},{"key":"10.1016\/j.purol.2023.08.004_bib1860","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00345-020-03149-4","article-title":"Classification of the renal papillary abnormalities by flexible ureteroscopy: evaluation of the 2016 version and update","volume":"39","author":"Almeras","year":"2021","journal-title":"World J Urol"},{"key":"10.1016\/j.purol.2023.08.004_bib1865","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/ndt\/gfab171","article-title":"Distal renal tubular acidosis: ERKNet\/ESPN clinical practice points","volume":"36","author":"Trepiccione","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.purol.2023.08.004_bib1870","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1055\/a-0848-8373","article-title":"Digital cholangioscopy-guided laser versus mechanical lithotripsy for large bile duct stone removal after failed papillary large-balloon dilation: a randomized study","volume":"51","author":"Angsuwatcharakon","year":"2019","journal-title":"Endoscopy"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708723001513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708723001513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:38:14Z","timestamp":1761115094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708723001513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":187,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1166708723001513"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2023.08.004","relation":{},"ISSN":["1166-7087"],"issn-type":[{"value":"1166-7087","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2022 Recommendations of the AFU Lithiasis Committee: Medical management\u00a0\u2013\u00a0from diagnosis to treatment","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2023.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}